As Roche Sequencing and Life Science looks ahead towards meeting tomorrow’s biggest needs in genomics, it’s clear that today’s sequencing technologies face limitations that can slow the development of faster speed, improved accuracy, greater scalability, and increased flexibility.
Some traditional sequencing technologies leverage a cycle-based approach for measuring the bases of the DNA, which delays access to usable data. While on-market single-molecule nanopore technologies address this challenge, they can be limited by fundamental signal-to-noise limitations—a result of both poor spatial resolution and the molecular distinction of nucleotide bases.